Accelerating Hcp Engagement in Myeloid Malignancies Through Real-world Data and Targeted Engagement
return on investment
unique providers identified
therapy eligible patients
The Challenge
The client needed to identify and engage HCPs managing newly diagnosed patients with myeloid malignancies and anemia in real time. Myeloid malignancies are complex diseases, and 40% of patients present with moderate to severe anemia at diagnosis. Timely identification and engagement were critical to support appropriate treatment decisions and improve patient outcomes.
Our Approach
Diaceutics implemented Physician Engage, using real-world, multimodal data to identify HCPs managing patients newly diagnosed with myeloid malignancies. The strategy included:
- Daily lab alerts to identify relevant HCPs
- Omnichannel engagement through email and banner advertising
- Personalized educational content delivered within 24 hours
- Real-time tracking of engagement metrics
- NPI-level targeting focused on opportunities to influence behavior
Collaboration Model:
An agile, data-driven program co-created with the client over 6 months.
Business-Critical Issues
- Delayed treatment decisions due to lack of timely HCP identification
- Limited therapy awareness among HCPs
- Potential loss of revenue and missed opportunities for therapy adoption
- Complexity of diagnosing myeloid malignancies
- Need for real-world evidence (RWE) to support HCP targeting
- Increasing demand for precision health approaches
External Factors
- Complexity of diagnosing myeloid malignancies
- Need for real-world evidence (RWE) to support HCP targeting
- Increasing demand for precision health approaches
Results & Impact
-
The program identified 2,398 patients and engaged 384 HCPs
-
The program delivered a 7X return on investment
Why It Matters
When treatment decisions move quickly, delayed HCP identification can mean missed opportunities for both patients and your brand. Physician Engage helps you identify relevant HCPs and deliver targeted education within 24 hours, giving your teams the opportunity to act earlier, build therapy awareness and support more timely treatment decisions. In this program, that approach identified 2,398 patients, engaged 384 HCPs and delivered a 7x return on investment.
About Diaceutics
At Diaceutics, our vision is Precision for All: a future where every eligible patient is identified, diagnosed and receives the right therapy at the right time.
For more than 20 years, we have helped biopharma companies overcome the diagnostic and commercialization barriers that stand between scientific innovation and patient impact. Today, we combine diagnostic intelligence, expert insight and targeted engagement to unlock the full potential of diagnostic-driven therapies - and more life for the patients they are designed to serve.
Testimonial
"Our customer reported that Physician Engage changed HCP behavior and increased treatment prescriptions."
Navigate complexity, accelerate adoption, and drive sustained growth.
Connect with us today to unlock your therapy's full potential.
Newsletter sign up
READY TO DO COMMERCIALIZATION DIFFERENTLY?
You might also be interested in?
Amplifying Your Precision Medicine Strategy: The role of Engagement Experts and Peer Networks
Enhance your precision medicine strategy through multi-modal communications and peer engagement, driving effective diagnostic commercialization and maximizing patient outcomes.